This inventor holds 1 USPTO granted patent. Top assignee: Hk Pharmaceuticals, Inc.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Eckart Leikauf
Introduction
Eckart Leikauf is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of chemistry, particularly in the development of multifunctional molecules. His innovative approach has led to advancements that are beneficial in various scientific applications.
Latest Patents
Eckart Leikauf holds a patent for a "Combinatorial protecting group strategy for multifunctional molecules." This patent describes the use of protection schemes and solid phase synthesis reactions to generate molecules of core structure M. These molecules possess multiple moieties, each of which can be individually deprotected or subsequently derivatized. The patent encompasses a range of compounds, including low molecular weight compounds such as saccharides, aminosugars, deoxysugars, nucleosides, nucleotides, coenzymes, amino acids, lipids, steroids, vitamins, hormones, alkaloids, and small molecule drugs. Additionally, it covers oligomeric compounds like oligosaccharides, oligonucleotides, peptides, or proteins. Eckart Leikauf has 1 patent to his name.
Career Highlights
Eckart Leikauf is currently associated with Hk Pharmaceuticals, Inc., where he continues to push the boundaries of innovation in pharmaceutical chemistry. His work has been instrumental in developing new methodologies that enhance the efficiency of synthesizing complex molecules.
Collaborations
Eckart collaborates with Hubert Koster, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving scientific advancements.
Conclusion
Eckart Leikauf's contributions to the field of chemistry through his innovative patent and ongoing work at Hk Pharmaceuticals, Inc. highlight his role as a significant inventor. His research continues to pave the way for new developments in multifunctional molecules.